Bluejay Diagnostics, Inc. (BJDX)

Every figure this model derived for BJDX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2022-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 9,598,916 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 9,814,952 AssetsCurrent 2026-06-30
current liabilities 2,116,641 LiabilitiesCurrent 2026-06-30
equity 9,414,840 StockholdersEquity 2026-06-30
revenue 249,040 Revenues 2022-12-31
sbc 0 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BJDX on one particular measure came for.

RatioValue
current ratio4.64
current ratio reported4.64
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about BJDX's figures. Written by the derivation as it ran, not added afterwards.